0
0
Is the advantage conferred by the heterologous regimen conserved after a booster dose of mRNA-based COVID-19 vaccine? - News-Medical.Net
2/23/23 at 1:35pm
Organization
News-Medical.Net
40 words
0
Comments
Researchers compared the efficacy of a third COVID-19 vaccine dose and that of homologous and heterologous regimens.
You are the first to view
https://www.news-medical.net/news/20230223/Is-the-advantage-conferred-by-the-heterologous-regimen-conserved-after-a-booster-dose-of-mRNA-based-COVID-19-vaccine.aspx
Create an account or login to join the discussion